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Abstract
Background: In Catalonia (Spain) breast cancer mortality has declined since the beginning of the 1990s. The
dissemination of early detection by mammography and the introduction of adjuvant treatments are among the
possible causes of this decrease, and both were almost coincident in time. Thus, understanding how these
procedures were incorporated into use in the general population and in women diagnosed with breast cancer is
very important for assessing their contribution to the reduction in breast cancer mortality. In this work we have
modeled the dissemination of periodic mammography and described repeat mammography behavior in Catalonia
from 1975 to 2006.
Methods: Cross-sectional data from three Catalan Health Surveys for the calendar years 1994, 2002 and 2006
was used. The dissemination of mammography by birth cohort was modeled using a mixed effects model and
repeat mammography behavior was described by age and survey year.
Results: For women born from 1938 to 1952, mammography clearly had a period effect, meaning that they
started to have periodic mammograms at the same calendar years but at different ages. The age at which
approximately 50% of the women were receiving periodic mammograms went from 57.8 years of age for women
born in 1938–1942 to 37.3 years of age for women born in 1963–1967. Women in all age groups experienced an
increase in periodic mammography use over time, although women in the 50–69 age group have experienced the
highest increase. Currently, the target population of the Catalan Breast Cancer Screening Program, 50–69 years
of age, is the group that self-reports the highest utilization of periodic mammograms, followed by the 40–49 age
group. A higher proportion of women of all age groups have annual mammograms rather than biennial or irregular
ones.
Conclusion: Mammography in Catalonia became more widely implemented during the 1990s. We estimated
when cohorts initiated periodic mammograms and how frequently women are receiving them. These two pieces
of information will be entered into a cost-effectiveness model of early detection in Catalonia.
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Background
In the European Union, age standardized breast cancer
mortality declined by 7% from 1988 to 1996 [1] and by
1.7% from 1997 to 2002 [2,3]. In Catalonia (Spain),
breast cancer was the leading cause of cancer death in
women during 1997–1998. After a sustained increase
starting in 1975–1976, mortality has declined 2.0% annu-
ally since 1989–1990 [4]. The dissemination of early
detection by mammography and the introduction of adju-
vant treatments are among the possible causes of this
decrease, and both were almost coincident in time. Thus,
understanding how these procedures were incorporated
into use in the general population and in women diag-
nosed with breast cancer is very important for determin-
ing which part of breast cancer mortality reduction was
attributable to early detection and which part to improved
breast cancer treatments.
In the United States of America (USA), several groups
modeled the effectiveness of mammography screening
between 1975 and 2000 [5]. One of the common inputs
of the models was the screening history of the cohorts
alive during the studied period, which was analyzed by
Cronin et al [6-8] at the National Cancer Institute (NCI).
Cronin et al used survey and mammography registry data
to develop a comprehensive model of mammography dis-
semination and use in the USA. Cronin's model consists
of two parts describing screening dissemination and usage
in US cohorts between 1975–2000. The first part describes
the initial screening distribution, while the second models
repeat screening behaviors. Together they tell us how
many and how often women are being screened by age
and birth cohort.
At the present time, there is interest in assessing the
impact and cost-effectiveness of breast cancer early detec-
tion programs in Catalonia (Spain). The goal of this arti-
cle is to model the dissemination of periodic and repeat
mammography behavior in Catalonia from 1975 to 2006.
We have been inspired by Cronin et al's work although we
have used a different methodological approach.
Methods
In Spain there is a National Health System (NHS),
financed mainly by taxes, which provides universal and
free health coverage, including early detection of breast
cancer. The NHS is organized on a regional basis and each
Autonomous Region has the responsibility for organizing
and providing health services to their population within
the general principles of the NHS. Catalonia is an auton-
omous region of Spain which has approximately one sixth
of the Spanish population. By the year 2007, the Catalan
Health Service was providing services to 7 million inhab-
itants, including 3.5 million women. The Catalan Breast
Cancer Screening Program (BCSP) started gradually at the
beginning of the 1990s providing biennial mammogra-
phy screening tests, with the target population being
women 50–64 years old. Since the year 2000, women
older than 64 are kept in the program until the age of 69.
In 2007, in Catalonia, there were some 773 000 and 529
000 women in the 50–69 and 40–49 age groups, respec-
tively. Before the start of and in addition to the BCSP,
there has also been a certain degree of opportunistic breast
cancer screening done in the public and private health
care sectors. In the period 2001–2003, participation in the
BCSP was 58% and the percentage of women having peri-
odic mammograms was 72%. Therefore, around 14% of
women in the BCSP target group received mammograms
outside of the program. [9].
To study dissemination and patterns of use of periodic
mammography, it would be desirable to have longitudi-
nal registry data for different cohorts of women in the
period of interest. This type of data does not exist in the
majority of countries. Instead, cross-sectional population
surveys may be used. In the USA, from the mid-1990s
onward, there exists a longitudinal population registry
available through the Breast Cancer Surveillance Consor-
tium (BCSC) which Cronin et al used to model repeat
screening behaviors. In Catalonia, there is no registry that
collects population-based longitudinal data on mammog-
raphy usage. Therefore, cross-sectional population surveys
are also a source of data used to estimate repeat screening
behavior.
We used cross-sectional data from three Catalan Health
Surveys in the calendar years 1994 [10], 2002 [11] and
2006 [12]. The three Catalan Health Surveys were house-
hold interview surveys with a stratified multi-stage sam-
pling design. Municipalities were selected with different
probabilities based on their size within each of the eight
Catalan Health Regions (strata). Then individuals were
selected randomly from the municipal censuses. To mini-
mize nonresponse when the selected sampling units were
not found or declined to participate, they were replaced by
extra units in the same age group, sex group, and neigh-
borhood. The sample sizes of the Catalan Health Surveys
were 15 000 individuals in 1994, 8 400 in 2002 and 18
126 in 2006.
We studied, first, how mammography has been dissemi-
nated in Catalonia by age and birth cohort, and second,
patterns of repeated screening.
Dissemination of periodic mammography, by age and birth 
cohort
Table 1 shows the number of women interviewed, and the
percentage of women using mammography periodically
in Catalonia, by year of birth and age group. These per-
centages were obtained by applying the sampling weightsBMC Cancer 2008, 8:336 http://www.biomedcentral.com/1471-2407/8/336
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to the responses reported in the survey. We used the com-
mands  svy  from the statistical package Stata  [13] to
account for the sampling design. Percentages in Table 1
correspond to the cross-sectional observed values of the
dissemination curves (see marks in Figure 1).
A mixed effects model was used to model the dissemina-
tion of periodic mammography, by age and birth cohort
[14]. Since the observed data from the Health Surveys
showed that the percentage p of women that use mammo-
grams periodically increased with age, except in the older
cohorts, the following logistic model was used:
where ϕ1 (asym) indicates the horizontal asymptote as age
increases, ϕ2 (xmid) indicates the age value at which the
response is ϕ1/2. It is the inflection point of the logistic
curve. The scale parameter ϕ3 (scal) can be interpreted as
the distance on the x-axis between the inflection point and
the point where the dependent variable p is approximately
0.75 ϕ1. In other words, ϕ1 represents the proportion at
which the dissemination curve levels off, or the highest
proportion of women that receive periodic mammogra-
phy, ϕ2 indicates the age at which half of the population
that will end up receiving periodic screening is already
receiving it, and ϕ3  indicates the difference in years
between the age at which 3/4 of the population is receiv-
ing periodic mammograms and the age ϕ2.
Mixed effects models are suitable for analyzing grouped
data and make it possible to incorporate both fixed effects,
which are parameters associated with the entire popula-
tion and random effects which are associated with individ-
ual units (in our analysis the individual units are cohorts of
p
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Percentage of women that receive periodic mammograms by age and cohort of birth Figure 1
Percentage of women that receive periodic mammograms by age and cohort of birth. Catalonia (Spain). The 
marks indicate the observed percentages at the Catalan health surveys in 1994, 2002, and 2006. The lines are the estimated 
percentages obtained using the mixed effects model   with parameters ϕ1 and ϕ3 fixed and parameter ϕ2 
random.
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birth). A mixed effects model allowed us to break down
the parameters ϕi, i = 1, 2, 3 as fi + ui where fi is the fixed
effect and ui is the random effect, a value from a normally
distributed variable with mean 0 and variance  . The
fixed effects part of the model summarizes the relation-
ship between the variables for all cohorts together,
whereas when the random effects are added to the fixed
effects, the relationship between variables within each
specific cohort is summarized. A small variance   for a
specific random effect, indicates that the random effect is
not significant and therefore there is no need to include it
in the model. The interpretation is that all cohorts have
similar behaviour with respect to this coefficient. In mixed
effects models some of the coefficients may be treated as
fixed and others as random, depending on the statistical
significance of the random effects.
We used the package nlme (non linear mixed effects mod-
els) of the R  software package for modeling [15].
Restricted maximum likelihood (REML) was used for
parameter estimation. The significance of the fixed effects
was tested using the t-test based on the REML estimate of
the variance and the significance of random effects was
tested using the likelihood ratio test.
Repeat mammography behavior
The dissemination curves do not provide information on
screening patterns, only on the fraction of women in the
population that have periodic mammograms. We have
used cross-sectional data from the Catalan Health Surveys
[10-12] to estimate repeat mammography behavior. The
proportion of women that reported having annual, bien-
nial or longer intervals between mammograms were
obtained, by age groups, from the 1994, 2002, and 2006
health surveys, taking into account the survey design.
Intervals between mammograms longer than two years
are named irregular intervals in this article.
Results
Percentage of women that receive mammography 
periodically, by age and birth cohort
Table 1 presents cross-sectional estimates of the percent-
age of women that received periodic mammograms by
cohort, calendar year and age group. Cohorts born
between 1938 and 1957 showed a period effect in the
1994 survey. They initiated periodic mammograms dur-
ing the same calendar year but at different ages. Approxi-
mately 40% or more of these cohorts reported having
periodic mammograms in 1994. In fact, in 1994, 37% of
women in the 52–56 age group, 45% of the 47–51 group
and 44% of the 42–46 group were exposed to periodic
mammograms. By 2002 (as reported in the 2002 survey),
these percentages had jumped to 70% or more, with the
1948–1952 cohort having the highest mammogram use.
This cohort also reported the highest use of periodic mam-
mograms (90%) in the 2006 health survey, at ages 54–58.
The increase between 2002 and 2004 was markedly less
than the increase between 1994 and 2002. It should be
noted that the dramatic changes between 1994 and 2002
took place over eight years, twice the lenght of time as
between 2002 and 2006. Eighty-five percent of women
from both the 1943–1947 and the 1953–1957 cohorts
indicated that they received periodic mammograms in
2006. Cohorts born between 1928 and 1937 experienced
a decrease in the proportion of women that reported hav-
ing periodic mammograms from the 2002 to the 2006
health surveys. There was also a slight decrease in the prev-
s u
2
s u
2
Table 1: Number of women interviewed and percent reporting having periodical mammograms
Birth cohort Periodically screened
1994 2002 2006
age n % age n % age n %
1913–1917 77–81 268 3.35 - - - - - -
1918–1922 72–76 358 5.63 - - - - - -
1923–1927 67–71 459 10.67 75–79 155 18.27 - - -
1928–1932 62–66 471 20.94 70–74 209 37.56 74–78 431 33.14
1933–1937 57–61 521 24.97 65–69 251 51.53 69–73 504 49.26
1938–1942 52–56 403 36.93 60–64 188 70.90 64–68 398 77.98
1943–1947 47–51 510 44.59 55–59 264 74.82 59–63 482 85.55
1948–1952 42–46 532 43.92 50–54 290 77.77 54–58 542 89.72
1953–1957 37–41 517 38.78 45–49 293 72.79 49–53 566 85.96
1958–1962 32–36 539 26.61 40–44 313 57.17 44–48 636 74.15
1963–1967 27–31 460 26.51 35–39 309 25.15 39–43 691 56.25
1968–1972 22–26 527 14.05 30–34 242 17.69 34–38 684 25.23
1973–1977 17–21 588 6.20 25–29 326 14.86 29–33 764 17.64
1978–1982 - - - 20–24 353 5.56 24–28 721 11.12
Catalan Health Surveys, calendar years 1994, 2002, and 2006.BMC Cancer 2008, 8:336 http://www.biomedcentral.com/1471-2407/8/336
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alence of periodic mammograms, for cohorts born in the
1963–1967 period, from 1994 to 2002.
Table 2 presents the mixed effects model for cohorts born
between 1938 and 1967. Cohorts born before 1938 did
not follow a logistic model since at older ages there was a
reduction in the percentage of women receiving periodic
mammograms. For cohorts born after 1967 there was not
enough data to estimate the parameters. Random effects
for the parameters ϕ1 (asym) and ϕ3 (scal) were not statis-
tically significant, indicating that all the studied cohorts
had similar values (Table 2, random effects section). The
parameter asym = 0.968 indicates that approximately 97%
of the women in each of the studied cohorts will end up
receiving periodic mammograms. The parameter ϕ2
(xmid) which indicates the age at which half of the popu-
lation is being screened periodically, had a significant ran-
dom effect, indicating that this age changed across the
studied cohorts. Thus, for cohorts born in 1948–1952,
approximately half of the population was receiving peri-
odic mammograms by age 45, for cohorts born in 1943–
1947 this happened at age 50, and for cohorts born in
1938–1942 this happened at age 57. For cohorts born
from the early 1960s onward, more than half of the
women were already receiving periodic mammograms
before the age of 40 (Table 2, random effect for parameter
ϕ2).
Figure 1 is the graphical representation of the logistic
curves. Marks in Figure 1 represent the observed data,
obtained from the responses to the surveys, and lines rep-
resent the estimated dissemination curves using the
model described in Table 2 with fixed parameters ϕ1 and
ϕ3 and random parameter ϕ2. For women born between
1938 and 1952, mammography clearly had a period
effect, meaning that they started to have periodic mam-
mograms in the same calendar years but at different ages.
Curves for cohorts born after 1952 appear closer, indicat-
ing that the incorporation of women into periodic screen-
ing had a similar age pattern between cohorts. More than
40% of women born in 1953–1957 were already receiving
periodic mammograms at age 40. This percentage
Table 2: Mixed effects logistic model* for estimating the percentage of women receiving periodic mammograms by age and cohort of 
birth
Fixed effects
Parameter Value Standard error p-value
ϕ1(Asym) 0.968 0.065 < 0.001
ϕ2(xmid) 45.004 3.091 < 0.001
ϕ3(scal) 5.384 0.640 < 0.001
Random effects
Parameter Standard deviation Residual
ϕ1(Asym)N S
ϕ2(xmid) 6.697 0.002
ϕ3(scal)N S
Random effect for parameter ϕ2 (xmid) by cohort of birth
Cohort of birth Random effect ** Fixed plus random ***
1938–1942 11.771 56.78
1943–1947 5.193 50.20
1948–1952 -0.244 44.76
1953–1957 -3.883 41.12
1958–1962 -5.160 39.84
1963–1967 -7.677 37.33
NS: Not significant.
* The model is:
 were p indicates the percentage of women receiving periodic mammograms, ϕ1 (asym) is the horizontal asymptote as 
age increases or the percentage at which the curve levels off, ϕ2 (xmid) indicates the age value at which approximately half of the population is 
receiving periodic mammograms and ϕ3 (scal) indicates the difference in years between the age at which 3/4 of the population is receiving periodic 
mammograms and the age ϕ2.
(**) The values indicate the departure from the fixed effect (45.0 years of age) for each cohort of birth. (***): The values can be interpreted as the 
age at which approximately 50% of the women will be receiving periodic mammograms.
p exp age = +−
f
ff
1
1 23 [( )/ ]BMC Cancer 2008, 8:336 http://www.biomedcentral.com/1471-2407/8/336
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increased to 50 and 60 percent for cohorts born in 1958–
1962 and 1963–1967, respectively. The curve for cohorts
born in 1963–1967 was estimated with data from women
younger than 45 years of age and should be interpreted
with caution.
Figure 2 presents the estimated dissemination curves, by
cohort of birth, distinguishing the fixed and random
effects. The blue line is the curve obtained using the fixed
effects and represents the modeling of all the cohorts
together, whereas the pink lines are specific for each
cohort (random effects) and are obtained using the corre-
sponding cohort-specific parameter ϕ2. Location of
cohorts below or above the overall dissemination curve
indicates differences in the percentage of women that
received periodic mammograms by age.
Repeat mammography behavior
Figure 3a shows the proportion of women classified as not
having mammograms or being annual, biennial or irregu-
lar screeners, by age and period. Figure 3b shows the pro-
portions, by age and period, among the screening users.
Women in all age groups have experienced an increase in
mammography use over time, although women in the
50–69 age group have experienced the highest increase.
Eighty eight percent of women 50–59 years old and 83%
of women 60–69 years old reported having periodic
mammograms in the 2006 health survey. Approximately
50% of women in these age groups had annual mammo-
grams, whereas 1/3 of the women 50–69 years old had
biennial mammograms (Figure 3b).
In the 40–49 age group, the percentage of women with
periodic mammograms increased from 43% in 1994 to
64% in 2002 and 2006. In this age interval, in the 2002
and 2006 health surveys, 40% of women reported having
annual mammograms, 20% biennial and 5% irregular
mammograms.
In the 70–79 age group only 6% of women reported hav-
ing periodic mammograms in 1994 whereas in 2006 this
percentage was 42%. Also, in this age group most of the
women that have mammograms have them annually.
Fixed and random effects obtained using a mixed effects model for the percentages of women that receive periodic mammo- grams, by age and cohort of birth Figure 2
Fixed and random effects obtained using a mixed effects model for the percentages of women that receive 
periodic mammograms, by age and cohort of birth. Catalonia (Spain). The fixed effects' curves represent the dis-
semination of mammography for all cohorts together, whereas the random effects' curves represent the dissemination of 
mammography for each specific cohort and are obtained using the corresponding cohort-specific ϕ2 parameter.
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In summary, we have evidence from the three Catalan
Health Surveys of a substantial increase over time in the
use of mammography, and a higher proportion of women
that have annual mammograms than biennial or irregular
mammograms.
Discussion
This paper studied the dissemination of periodic mam-
mography and repeat mammography behavior in Catalo-
nia (Spain), from 1975 to 2006. First, we modeled the
percentage of women receiving periodic mammograms by
age and cohort of birth. Second, we described patterns of
repeated use over time. Third, we obtained one of the
inputs that will be used in the near future for modeling
the effectiveness of early detection and adjuvant treatment
on the reduction of breast cancer mortality in Catalonia,
Spain.
Limitations
One of the limitations of our study is the fact that our data
comes from self-reported information from a representa-
tive population sample. Recall bias may affect the infor-
mation that individuals report in the interview. Self-
reported information has commonly been used to study
mammography utilization across populations and time
periods. Bancej et al [16] used longitudinal panel data
from a representative cohort of women to examine the
prevalence of inconsistent self-reports of mammography
utilization in Canada, as assessed in 1994–95 (baseline)
and 1996–97 (follow-up). Among women who reported
having a mammogram at baseline, 5.9% reported at fol-
low-up that they had never had one. Among women
reporting never using mamography at baseline and at
least one mamography at follow-up, 17.4% reported their
most recent mammogram as occurring prior to 1994–95
(baseline) and such responses were more common
among women aged 70+ years and those in poorer health.
a – Proportion of women that fall in the categories of not having periodic mammograms or having mammograms annually, bien- nially or irregularly, by age and period Figure 3
a – Proportion of women that fall in the categories of not having periodic mammograms or having mammo-
grams annually, biennially or irregularly, by age and period. 3b – Proportion of women that fall in the categories of 
having mammograms annually, biennially or irregularly among those that declared to have periodic mammograms, by age and 
period.
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Rivera et al [17] assessed the reliability of the self-reported
lifetime number of mammograms, most recent mammo-
gram date, and predictors of reliability in women veterans
in the US. Reliability of the lifetime number of mammo-
grams was 61% for exact consistency and 80% for consist-
ency within one mammogram. Only 35% of women in
the Rivera study were exactly consistent in reporting mam-
mogram date and 55.6% were consistent within 3
months. White race/ethnicity, having a Bachelor's degree,
reporting a healthcare provider's recommendation for a
mammogram and having a screening mammogram were
associated with consistency in reporting date. Although
these studies point to potential measurement error, the
fact that our study is derived from questions about utiliza-
tion at the time of the survey, recall bias may have a lower
impact in our data.
To support the validity of our data, on one hand we have
other studies done in Catalonia that are consistent with
our results. The BCSP has reported the percentages of
women in the screening target group (aged 50 to 69) that
either participated in the BCSP or have reported to the
program that they had received recent mammograms, for
the period 2001–2003 [9]. These values were consistent
with the reported data of the 2002 Catalan Health Survey.
Another survey of about 1600 women in the city of Barce-
lona in 1992, found that 27% of women aged 30–39 and
38% of women aged 40–49 reported having periodic
mammograms [18]. These results also agree with our esti-
mated curves (see ages 30–39 for cohorts born in 1953–
57 and 1958–62, and ages 40–49 for cohorts born in
1943–47 and 1948–52). In addition, Segura et al inter-
viewed around 8800 women aged 50 to 64 years in Barce-
lona in 1991, prior to initiating a population-based breast
cancer screening program (which is part of the BCSP)
[19]. Around 60% of these women reported having had
screening mammography in the last 4 years, and mam-
mography use was higher among women who were
younger. These results are compatible with those obtained
with our model (see dissemination curve for cohorts born
in 1938–42). On the other hand, data in other countries,
such as the US, suggests a similar pattern of mammogra-
phy use, principally for the younger cohorts [6]. In the US,
Cronin et al estimated that the percentage of women who
had ever been screened for cohorts born in 1938–1942
was higher than 95%. On the other hand, in the US,
cohorts born in 1948 or later had more than 50% of
women ever screened before age 35. Even though Cronin
et al studied the percentage ever screened and we have stud-
ied the percentage with periodic mammograms, we think that
in both places a high percentage of women are regular
mammography users when they reach the age of 40.
A second limitation arises from the Catalan Health Sur-
veys' interviewees not being asked if their mammograms
were for diagnosis or screening. Therefore, we have prob-
ably overestimated the cumulative distribution for the
time to the first periodic mammogram for screening pur-
poses. Cronin et al [6] estimated that 2% of the mammo-
grams recorded in the Breast Cancer Surveillance
Consortium were performed within nine months of the
previous exam and therefore could be done for diagnostic
reasons. Consequently, we think that there is minimal
impact from overestimating the mammograms for screen-
ing purposes in the parameter estimates of the dissemina-
tion curves.
A third limitation occurs from the unlikely assumption of
population stationarity that we made when combining
cross-sectional data to estimate dissemination of mam-
mography. In Catalonia, after a baby boom during the
seventies, there were minor changes in the demographic
structure between 1980 to 1994. The size of the popula-
tion remained around 6 million inhabitants and mortal-
ity and fertility experienced a decreasing trend that
resulted in an ageing population. From 1995 to 2006
there has been a dramatic increase in economic immigra-
tion, principally young individuals coming from less
developed countries, that has produced a jump from 6 to
7 million inhabitants and modified the demographic age,
sex, and socioeconomic structure [20]. Until now there
has been no available data analyzing the impact of immi-
grants on mammography use in Catalonia. Since immi-
grants are mostly young, their impact on mammography
utilization would be more marked in younger age groups.
Some authors in Spain have reported higher usage of
screening mammography in younger women with higher
socioeconomic or educational status and private health
insurance [18,21]. In consequence, the impact of immi-
gration in Catalonia may have produced a decrease in the
frequency of periodic mammography utilization in the
younger cohorts, consistent with the decline that we have
observed in our data.
A fourth limitation is that we use growth curves to study
the use of periodic mammography, a phenomenon that
can show a decreasing pattern at older ages. In fact, we
have seen a decrease in the proportion of women that
report having periodic mammograms in the oldest age
groups. This finding is consistent with the guidelines for
screening in our region, where women 70 years and older
are no longer invited for periodic mammograms, free of
charge, by the public health system. A way to avoid this
limitation would be to restrict the analysis to women
under 70. In fact, the curves that we could estimate corre-
sponded to cohorts that were under 70 at the last health
survey, in 2006. For earlier cohorts, we have presented the
observed prevalences of periodic mammography use by
age.BMC Cancer 2008, 8:336 http://www.biomedcentral.com/1471-2407/8/336
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Fifth, our work was inspired by the work that Cronin et al
did in the US, which adapted a standard diffusion of inno-
vation model proposed by Rogers [6,22]. In the US,
Cronin et al used data from seven national health inter-
views and estimated the parameters of the dissemination
curve for each cohort separately. In Catalonia, there were
only three national health surveys that provided data on
mammography use. We started using the diffusion of
innovation model and compared the results with a mixed
effects model. Dissemination curves were similar with
both methods, but since our mixed effects model com-
bined data from all cohorts, it gave us more stable param-
eter estimates and also provided an interesting
interpretation of how cohorts had differential patterns of
use of periodic mammography over time.
Dissemination of mammography
For the first part of the analysis, the mammography dis-
semination model in Catalonia, we used mixed effects
models which incorporate both fixed effects and random
effects. In most cases, random effects are associated with
individual units drawn at random from a population. But
mixed models can also be applied to data that present
some type of correlation, like longitudinal or nested data,
or in meta-analysis to assess heterogeneity of studies.
Quoting Pinheiro and Bates: "mixed models provide a flexi-
ble and powerful tool for the analysis of grouped data" [14].
Since birth cohorts are affected by events that make indi-
viduals within cohorts more similar than individuals from
different cohorts, it can be assumed that cohorts introduce
a grouping characteristic in our data. Our mixed model
estimated the relation between the percentage of women
that use periodic mammography by age, assuming that
this relation could vary among cohorts of birth. There are
other examples in the literature where the cohort effect
has been treated as a random effect. O'Brien et al used a
mixed model to estimate age, period and cohort effects
[23]. They treated the cohort effects as random effects and
age and period effects as fixed. Assuming that the effects of
membership in particular cohorts are variable instead of
fixed, they solved the problem of identifiability of age-
period-cohort models and, in addition, they showed how
cohort characteristics can be used to explain the variance
that is associated with cohorts and is independent of age
and period.
We have based our analysis on the three available cross-
sectional studies: the Catalan Health Surveys performed
in 1994, 2002, and 2006. This fact limited the ability to
estimate the parameters of the dissemination curves for
the oldest and youngest cohorts that we present in Table
1. We have limited this analysis to cohorts born between
1938 and 1967 because the estimated parameters for
these subgroups of cohorts were stable and precise.
Cohorts born during the 1940s and the beginning of the
1950s started to have periodic mammograms during the
1990s, at different ages. That indicates a period effect asso-
ciated with the introduction of a new diagnostic test,
which was also described by Cronin et al in the USA [6].
Dissemination curves for Catalan cohorts born after 1952
appear closer in the graph, indicating the end of the
period effect and the incorporation of women into peri-
odic screening at similar ages.
The Catalan BCSP covered the target population (women
50–64 years old) by the end of the 1990s and was
extended to women 69 years old in the year 2000. In
2004, 61.2% of the invited women participated in the
BCSP and 75.7% either participated in the BCSP or
reported to the BCSP that they had received recent mam-
mograms (non-published BCSP data). These values are
slightly higher than the corresponding values reported by
the BCSP for the period 2001–2003 [9]. The 2006 Catalan
Health Survey shows an increase in the percentage of
women that reported having periodic mammograms in
the target group, being almost 90% in the 50–59 group
and more than 80% in the 60–69 group.
There has been a dramatic increase in the use of periodic
mammography at ages 40–49, an age interval not covered
by the BCSP, for women born during the 1950s. This
increase has stabilized near 75% for women born at the
beginning of the 1960s, as Table 1 and Figure 1 show.
Masuet et al [24] reported that Catalan women in the 40–
49 age group had the highest prevalence of mammogra-
phy use in 1994, but were surpassed by women in the 50–
69 age groups in 2002. In addition, there has been an
increase in mammography use over time, in women in
their late 30s or early 40s, which can be measured by the
change in the age at which approximately half of the
cohort is already receiving periodic mammograms. This
age went from 57 years for cohorts born in 1938–1942 to
37 years for cohorts born in 1963–1967. In cohorts born
at the end of the 1950s, more than half of the women were
receiving periodic mammograms at the age of 40. There-
fore, opportunistic screening is being done in Catalonia,
in young women, at ages where screening mammography
is still controversial.
Finally, women in their early 30s, while in 1994 one in
four reported periodic mammography use, in 2002 and
2006 this figure was one in six. Reasons for this decrease
may have been, a) a change in the sociodemographic
composition of these age groups due to the arrival of
immigrant women, probably less exposed to preventive or
screening practices, b) a higher level of consensus, for this
age group, among health professionals regarding evidence
and criteria for screening mammography, and c) the active
role of the Catalan health authorities for adherence to theBMC Cancer 2008, 8:336 http://www.biomedcentral.com/1471-2407/8/336
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European guidelines [25]. In Catalonia, before the advent
of the BCSP, private health services actively encouraged
the use of mammography in young women.
Repeat mammography behavior
Since there are no longitudinal registries of mammogra-
phy in Catalonia, we have limited our analysis to a
description of mammography usage patterns (non-user,
annual, biennial, irregular) based on health surveys from
1994, 2002, and 2006.
Whereas the Catalan BCSP currently invites women in the
50–69 age interval for biennial mammograms, our results
show that annual mammography is the most prevalent
pattern in Catalan women of all age groups. According to
our data, 50% of the Catalan women in the 50–69 age
group receive annual mammograms and only one third
receive biennial mammograms (Figure 2b), as recom-
mended in the BCSP. Since about 2/3 of the invited
women participate in the Catalan BCSP, there might be a
group of women that receive mammograms both inside
and outside the BCSP. If we assume that all the women
50–69 that receive biennial mammograms receive them
in the BCSP, there may be a subset of women that partici-
pate in the BCSP irregularly and another fraction that
receive additional mammograms in the public health sys-
tem outside the BCSP or in the private health system.
It seems that in Catalonia periodic screening outside the
BCSP is associated with higher socioeconomic status.
And, from our data, it is easy to conclude that the majority
of women that receive regular mammograms outside the
BCSP receive annual mammograms. Bare et al [26] stud-
ied the behavior of women with respect to early detection
of breast cancer prior to being invited to participate in a
screening programme and factors associated with partici-
pation, in an area of Catalonia in the mid 1990s. More
than 70% of the women reported that they had under-
gone mamography before the program was started.
Around 60% of the women that reported having had
mammograms received them less than 2 years previously.
Factors associated with non-participation in the screening
program were higher level of education, higher occupa-
tional skills or working at home, self- or gynaecological
examination of breasts, and having received hormone
replacement therapy. Borras et al [21] and Borrell et al [27]
found that Catalan women who reported having volun-
tary private health insurance (one quarter of the women's
population) in addition to the universal insurance that all
resident women have, were more likely to have had a reg-
ular mammography.
Conclusion
Mammography in Catalonia started during the 1980s but
spread during the 1990s. The modeling of mammography
dissemination using a mixed effects model has facilitated
an understanding of when cohorts started using mam-
mography on a regular basis. Currently, more than half of
women are receiving periodic mammograms in Catalonia
at age 40.
In Catalonia, the target population of the Catalan Breast
Cancer Screening Program, 50–69 years of age, is the
group that reports the highest use of periodic mammo-
grams, followed by the 40–49 age group.
The majority of women that receive periodic mammo-
grams have them annually.
Finally, we have estimated when cohorts started the use of
periodic mammograms and how frequently women are
receiving periodic mammograms. These two pieces of
information will be entered into a cost-effectiveness
model of early detection in Catalonia.
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